FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma

Zeyu Zhang(Chongqing Medical University), Changzhu Duan(Chongqing Medical University), Yarui Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingxi Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaobing Wang(Shanghai Changzheng Hospital), Xiaolei Guo(Yangzhou Polytechnic Institute), Qing Zhu(Sichuan University)
Frontiers in Pharmacology
October 8, 2021
Cited by 209


Related Papers